Mitchell Capital Management’s Pfizer PFE Stock Holding History

Mitchell Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-11,763	Closed	-$396K	–	111
2018 Q1	$396K	Buy	11,763 +4,790	+69%	+$165K	0.14%	88
2017 Q4	$240K	Buy	+6,973	New	+$238K	0.08%	86

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mitchell Capital Management's PFE Position: Q2 2018 in Review

Mitchell Capital Management sold out of Pfizer (PFE) in Q2 2018, closing a stake of 11,763 shares — an estimated $396K sold.

Mitchell Capital Management first reported a position in PFE in Q4 2017 and held it in 2 quarters. The position peaked at $396K in Q1 2018. 2,204 funds tracked by Wall St. Rank hold PFE as of Q2 2018.

Mitchell Capital Management reported no remaining Pfizer position as of Q2 2018 after selling out during the quarter.
Mitchell Capital Management sold 11,763 Pfizer shares in Q2 2018, an estimated $396K.
Mitchell Capital Management first reported a position in Pfizer in Q4 2017 and held it in 2 quarters.
Mitchell Capital Management's Pfizer position peaked at $396K in Q1 2018.
2,204 funds tracked by Wall St. Rank held Pfizer as of Q2 2018.

Based on Mitchell Capital Management's 13F filing for Q2 2018, filed 10 Aug 2018.